Dr. DCL, Nucleaire geneeskunde SRL
Dr. DCL, Nucleaire geneeskunde reported total assets of 107,846 € at the end of the 2025 financial year (annual accounts filed with the NBB on 19 Jul 2026).
The score of Dr. DCL, Nucleaire geneeskunde shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -94 % Total assets -46 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. DCL, Nucleaire geneeskunde's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 84,151 € | ||||
| Equity | 6,847 € | ||||
| Cash | 34,980 € | ||||
| EBITDA | 115,174 € | ||||
| Total assets | 107,846 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 19 Jul 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Dr. DCL, Nucleaire geneeskunde's financial analysis
- Solvency6.3%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. DCL, Nucleaire geneeskunde
Dr. DCL, Nucleaire geneeskunde's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0734.478.060
- VAT number
- BE0734478060
- Peppol
- Registered · 0208:0734478060 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Sep 2019
- Registered office
- 1600 Sint-Pieters-Leeuw
- Latest accounts
- 2025 · filed on 19 Jul 2026
- Activity
- Medical specialists activities (NACE 86220)
Dr. DCL, Nucleaire geneeskunde (SRL) has been based in Sint-Pieters-Leeuw since 2019, active in: medical specialists activities. For 2025, it reports a net profit of 84,151 € and equity of 6,847 €; its revenue is not published. Its solvency stands at 6.3%, below the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. DCL, Nucleaire geneeskunde
Companies in the same business, of comparable size and area, outside its group.
Frequently asked questions about Dr. DCL, Nucleaire geneeskunde
What is the revenue of Dr. DCL, Nucleaire geneeskunde?
Dr. DCL, Nucleaire geneeskunde files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. DCL, Nucleaire geneeskunde?
In Belgium, the VAT number is the company number prefixed with BE: BE0734478060 for Dr. DCL, Nucleaire geneeskunde, if the company is VAT-registered. Its company number (CBE) is 0734.478.060.
Where is the registered office of Dr. DCL, Nucleaire geneeskunde?
According to the CBE register, the registered office of Dr. DCL, Nucleaire geneeskunde is in 1600 Sint-Pieters-Leeuw.
What is the equity of Dr. DCL, Nucleaire geneeskunde?
At the close of the 2025 financial year, the equity of Dr. DCL, Nucleaire geneeskunde amounts to 6,847 €, a solvency of 6.3% of total assets.
Who manages Dr. DCL, Nucleaire geneeskunde?
The register lists 1 active mandates at Dr. DCL, Nucleaire geneeskunde. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dr. DCL, Nucleaire geneeskunde
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →